Skip to main content
. 2022 Apr 26;2022(4):CD009261. doi: 10.1002/14651858.CD009261.pub7

NCT01759381.

Study characteristics
Methods Study design: randomised controlled trial
Study grouping: parallel design
Ethics and informed consent: not stated
Follow‐up period: 3 months
Sample size estimate: not reported 
ITT analysis: not reported
Funding: not reported
Preregistration: NCT01759381
Participants Location: USA
Intervention group (NPWT): 11 participants; group 2 (control group): 8 participants; however, this study was terminated earlier and the estimated sample size was unclear
Mean age: not reported as mean values
Inclusion criteria: >/= 18 years of age; >/= 3 level instrumented thoracic, lumbar, or thoracolumbar spinal fusion
Exclusion criteria: < 18 years of age; < 3 level instrumented thoracic, lumbar, or thoracolumbar spinal fusion; spinal infection at time of surgery; history of immunosuppression or chronic systemic infection; pregnancy; inability to provide informed consent.
Interventions Aim/s: "to evaluate the outcome of incisional negative pressure wound therapy in preventing surgical site infections and wound complications (dehiscence) in high‐risk patients undergoing complex spinal surgery"
Group A (NPWT) intervention: NPWT received as opposed to the standard incisional dressing following complex spinal surgery.
Group B (control) intervention: no negative pressure wound therapy device; postoperative dressings per the surgeon's standard routine.
Study date/s: December 2012 to June 2015
Outcomes Death
Number of participants with postoperative infection
Validity of measure/s: not given
Time points: 3 months after surgery
Notes Information is from NCT01759381 registry. This study was terminated earlier and the estimated sample size was unclear. Data were available only for 19 participants.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Quote: "The allocation of patients (no NPWT device versus applying an NPWT device) will be determined by computer‐generated randomization".
Comment: low risk of bias as a proper randomisation method was used.
Allocation concealment (selection bias) Unclear risk No information
Blinding of participants and personnel (performance bias)
All outcomes High risk High risk of bias as NCT01759381 stated this was an open‐label trial.
Blinding of outcome assessment (detection bias)
All outcomes High risk High risk of bias as NCT01759381 stated this was an open‐label trial.
Incomplete outcome data (attrition bias)
All outcomes Unclear risk No information. The trial was terminated earlier and the estimated sample size was unclear.
Selective reporting (reporting bias) Low risk All prespecified outcomes were reported in records of NCT01759381.
Other bias Unclear risk This study was terminated earlier and it was unclear how the early stopping affected the study results.